| Cash flow (USD) | FY 2026 ended May 31, 2026 | FY 2025 ended May 31, 2025 | FY 2024 ended May 31, 2024 | FY 2023 ended May 31, 2023 | FY 2022 ended May 31, 2022 | FY 2021 ended May 31, 2021 |
|---|---|---|---|---|---|---|
| Net income | -3.77M | -4.97M | -5.98M | -7.14M | -4.53M | -7.45M |
| Depreciation and amortization | 77.0K | 87.0K | 81.0K | 84.0K | 339.0K | 105.0K |
| Stock-based compensation | 476.0K | 460.0K | 837.0K | 1.19M | 1.26M | 1.35M |
| Cash from operations | -3.42M | -3.84M | -5.36M | -5.47M | -479.0K | -5.25M |
| Capital expenditure | -51.0K | -64.0K | -57.0K | -135.9K | ||
| Free cash flow | -5.41M | -5.54M | -536.0K | -5.39M | ||
| Cash from investing | -1.0K | -37.0K | -115.0K | -78.0K | -170.0K | -295.6K |
| Cash from financing | 2.33M | 2.11M | -81.0K | 9.39M | 2.39M | 1.11M |
| Net change in cash | -1.09M | -1.77M | -5.55M | 3.80M | 1.72M | -4.44M |
From Biomerica Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.